Jianjun Peng Selected Research

Jianjun Peng Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 05/2014
15	Stomach Neoplasms (Stomach Cancer) 02/2024 - 01/2014
10	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2012
7	Myocardial Infarction 09/2023 - 01/2014
6	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2015
6	ST Elevation Myocardial Infarction 10/2018 - 01/2016
4	Colonic Neoplasms (Colon Cancer) 12/2018 - 10/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2023 - 01/2014
3	Liver Neoplasms (Liver Cancer) 10/2021 - 05/2014
3	Carcinoma (Carcinomatosis) 01/2020 - 11/2012
3	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2016
3	No-Reflow Phenomenon 10/2018 - 01/2016
2	Hypertension (High Blood Pressure) 01/2023 - 11/2018
2	Lymphoma (Lymphomas) 01/2022 - 03/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2014
2	Cardiotoxicity 01/2021 - 11/2018
2	Postoperative Pain 01/2020 - 09/2018
2	Hypoxia (Hypoxemia) 01/2020 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 09/2018
2	Peritoneal Neoplasms 01/2020 - 09/2018
2	Thrombosis (Thrombus) 04/2018 - 01/2014
2	Carcinogenesis 12/2016 - 11/2016
2	Leukemia 01/2016 - 03/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 03/2015
1	Reperfusion Injury 01/2023
1	Adenocarcinoma 01/2023
1	Atrophic Gastritis 01/2021
1	Microsatellite Instability 01/2021
1	Infections 01/2021
1	Flatulence 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Pain (Aches) 01/2020
1	Heart Diseases (Heart Disease) 11/2018
1	Acute Kidney Injury (Acute Renal Failure) 09/2018
1	Glioma (Gliomas) 09/2018
1	Aneurysm (Aneurysms) 01/2018

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2015
6	hispidulinIBA 01/2020 - 05/2014
5	Long Noncoding RNAIBA 12/2022 - 08/2016
4	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2022 - 03/2015
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2015
3	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 03/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2015
3	MicroRNAs (MicroRNA)IBA 12/2016 - 10/2015
3	FlavonoidsIBA 01/2016 - 01/2015
2	CholesterolIBA 02/2024 - 11/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 11/2018 - 02/2015
2	Cadherins (E-Cadherin)IBA 01/2018 - 01/2015
2	omega-Chloroacetophenone (Mace)IBA 12/2016 - 01/2014
2	mitochondrial transcription factor AIBA 12/2016 - 10/2015
1	HMPL-013IBA 04/2024
1	Trastuzumab (Herceptin)FDA Link 02/2024
1	MTOR InhibitorsIBA 02/2024
1	Cell-Free Nucleic AcidsIBA 02/2024
1	PTX3 proteinIBA 09/2023
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 09/2023
1	C-Reactive ProteinIBA 01/2023
1	6-methyladenineIBA 12/2022
1	SB 225002IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Protons (Proton)IBA 01/2022
1	HDL CholesterolIBA 10/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Circular RNAIBA 01/2021
1	beta-Galactosidase (Lactaid)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Sudan Black BIBA 01/2021
1	MB Form Creatine KinaseIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	LigandsIBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	CytosineIBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2020
1	Capecitabine (Xeloda)FDA Link 11/2018
1	RNA IIBA 09/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	Cetuximab (Erbitux)FDA Link 01/2018
1	ChloridesIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2017
1	LuciferasesIBA 12/2016

Therapy/Procedure

8	Percutaneous Coronary Intervention 01/2023 - 01/2016
7	Therapeutics 02/2024 - 03/2014
4	Drug Therapy (Chemotherapy) 04/2024 - 12/2016
3	Gastrectomy 01/2018 - 01/2014
2	Immunotherapy 01/2021 - 01/2021
2	Hyperthermic Intraperitoneal Chemotherapy 01/2020 - 09/2018
1	Neoadjuvant Therapy 01/2023
1	Enteral Nutrition (Feeding, Tube) 01/2020
1	Duration of Therapy 11/2018
1	Length of Stay 09/2018
1	Cytoreduction Surgical Procedures 09/2018